The proof of what I have posted about the CSM sucker fish fab 7... the pap is a laughing stock in the industry...
----------------------------------------------------------------------------------------------
http://sgmarkettalk.files.wordpress...investment-daily-thursday-10-january-2008.pdf
1Q08 preview — We expect sales to decline 7% qoq in 1Q08 before picking
up only modestly in 2H08.
Fab 7’s utilization has not risen appreciably, thus
CHRT’s product mix is unlikely to improve and breakeven utilisation could
remain above 80% (vs. 70% in 3Q06). Longer term, CHRT's competitive
edge could be eroded by SMIC’s recent 45nm CMOS licensing agreement
with IBM. The deal has enhanced SMIC’s so far lagging technology roadmap.
When it begins production in 2009, the pressure on CHRT’s ASP would
increase.